510(k) K092274
K092274 is an FDA 510(k) premarket notification submitted by Randox Laboratories, Ltd. for the device "RANDOX BENZODIAZEPINE ASSAY". The FDA issued a decision of Substantially Equivalent on Oct 15, 2010. The device falls under product code JXM (Enzyme Immunoassay, Benzodiazepine), a Class II device regulated under 21 CFR 862.3170. Randox Laboratories, Ltd. has 115 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Oct 15, 2010
- Date Received
- Jul 28, 2009
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Enzyme Immunoassay, Benzodiazepine
- Device Class
- Class II
- Regulation Number
- 862.3170
- Review Panel
- TX
- Submission Type
- 510(k)
Need the full FDA record for Randox Laboratories, Ltd.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.